Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children
about
The Ile198Thr and Ala379Val variants of plasmatic PAF-acetylhydrolase impair catalytical activities and are associated with atopy and asthmaAssociation of a G994 -->T missense mutation in the plasma platelet-activating factor acetylhydrolase gene with risk of abdominal aortic aneurysm in JapanesePlatelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipaseLipoprotein-associated phospholipase A2 prognostic role in atherosclerotic complicationsEnhancement of leukotriene B4 release in stimulated asthmatic neutrophils by platelet activating factorPlatelet aggregation unchanged by lipoprotein-associated phospholipase A₂ inhibition: results from an in vitro study and two randomized phase I trialsCarriage of the V279F null allele within the gene encoding Lp-PLA₂ is protective from coronary artery disease in South Korean malesRelationship between platelet activating factor acetylhydrolase activity and apolipoprotein B levels in patients with peanut allergy.The genetic basis of atopic asthma.Deficiency of platelet-activating factor acetylhydrolase is a severity factor for asthmaBronchial hyperreactivity, increased endotoxin lethality and melanocytic tumorigenesis in transgenic mice overexpressing platelet-activating factor receptor.Events at the vascular wall: the molecular basis of inflammation.PAF acetylhydrolase gene polymorphisms and asthma severity.Circulating platelet-activating factor is primarily cleared by transport, not intravascular hydrolysis by lipoprotein-associated phospholipase A2/ PAF acetylhydrolasePlatelet activating factor contributes to vascular leak in acute dengue infection.PAF receptor antagonist Ginkgolide B inhibits tumourigenesis and angiogenesis in colitis-associated cancer.Platelet-activating factor and normal or leukaemic haematopoiesis.Platelet-activating factor, a pleiotrophic mediator of physiological and pathological processes.Partial characterization of lipids that develop during the routine storage of blood and prime the neutrophil NADPH oxidase.Lipoprotein-associated phospholipase A2 and risk of incident cardiovascular disease in a multi-ethnic cohort: The multi ethnic study of atherosclerosis.PLA2G7 genotype, lipoprotein-associated phospholipase A2 activity, and coronary heart disease risk in 10 494 cases and 15 624 controls of European AncestryPLAC test for identification of individuals at increased risk for coronary heart disease.Modulation of oxidative stress, inflammation, and atherosclerosis by lipoprotein-associated phospholipase A2Determination of phospholipase activity of PAF acetylhydrolaseMacrophage VLDL receptor promotes PAFAH secretion in mother's milk and suppresses systemic inflammation in nursing neonates.Cigarette smoke exposure inhibits contact hypersensitivity via the generation of platelet-activating factor agonists.PAF and Haematopoiesis. I. 5-Fluoro-Uracil Induces PAF Production in Haematopoietic Organs of Rats.Lipid oxidation in carriers of lecithin:cholesterol acyltransferase gene mutations.Lipoprotein-associated phospholipase A2 and risk of venous thrombosis in older adults.The prevalence of platelet activating factor acetylhydrolase single nucleotide polymorphisms in relationship to necrotizing enterocolitis in Northwest Louisiana infants.Hypothesis: hemolytic transfusion reactions represent an alternative type of anaphylaxisA previously unreported impact of a PLA2G7 gene polymorphism on the plasma levels of lipoprotein-associated phospholipase A2 activity and mass.Differential expression of platelet-activating factor acetylhydrolase in lung macrophages.Functional Consequences of Mutations and Polymorphisms in the Coding Region of the PAF Acetylhydrolase (PAF-AH) Gene.Platelet-activating factor and related acetylated lipids as potent biologically active cellular mediators.Receptor-dependent metabolism of platelet-activating factor in murine macrophages.Investigation of a Bicyclo[1.1.1]pentane as a Phenyl Replacement within an LpPLA2 Inhibitor.Oxygen radicals inhibit human plasma acetylhydrolase, the enzyme that catabolizes platelet-activating factorPlatelet-activating factor (PAF) stimulates the production of PAF acetylhydrolase by the human hepatoma cell line, HepG2.Expression of the platelet-activating factor receptor results in enhanced ultraviolet B radiation-induced apoptosis in a human epidermal cell line.
P2860
Q24540170-74C1627D-0FD8-466F-BAB6-0E46D843DFA2Q24542068-16FAD416-CBDC-42CF-BE00-B08931D039B2Q24562119-FAA76136-F80E-4C84-9553-4A6D6B4E6507Q26777871-0A9B5D40-3828-4517-8BED-003F8C238BD8Q28379398-731FD39E-A181-4BF6-8237-51658E6A159BQ28539153-9D175E8F-6BC9-4F65-89ED-10A5AAB46E60Q28741376-4ADAAA6A-6560-4122-8EA7-C01E18647C9AQ33575941-AC5CF34B-ED84-4445-92E7-AF20EE9B6036Q33717431-056EFFAB-7902-4968-BE73-A472B8D7649AQ33848692-540E71CD-D7B1-40DF-808F-A5EFA3259F35Q33885948-D00762F9-E20A-462E-93AE-7AFF468744A0Q34161044-9AF20B3B-0AFB-440A-951E-16B8091A130FQ34355213-EAE36902-7E60-46B2-A873-BE2C7C4E07D4Q34670677-85AAE022-47A1-49A1-9FF1-1E62AACBE9D1Q35043739-CF61942E-5459-4C6E-9586-FEB19ED973B6Q35145112-CCBB2E7E-2755-471C-905B-9ED2E2D4C833Q35152617-9F62835D-3CC0-4176-8085-599A0C8BE81AQ35621992-F5C89EA1-C940-4AFF-BBA7-5E3F4EDC86C1Q35673608-5FBE6CE3-C548-4212-BFB5-9C292290B121Q35856590-5391F318-3F88-4BF1-9FB6-B8E579A15162Q36041389-C7B09A97-6281-4AC0-A79B-C57A8713EE06Q36050527-BC11474B-4E1A-4CA6-8DD9-BDFBDB88FD54Q36145180-AD093401-2C60-4195-8B18-92327C83E380Q36240691-919460B3-6AD7-4E37-BFF6-A36E0CB9E328Q36462361-66F4A957-7E94-42F7-AEE4-91CA352E6088Q36625266-9EC0BAC5-E0B1-42A2-B470-69C2CC7D6D80Q36631605-8E802C1F-1A0A-4A96-B61C-55D50AB3FE56Q36723319-C2B6DA62-332C-4698-A1B7-E9786EB1BBCCQ37001368-24FCDA47-C7E6-4A19-AB3E-66410D0B07CBQ37009251-C481E269-0562-41EA-9B71-F916F75ACFF8Q37284681-6556D08B-BBC0-440A-8289-B1A1C079BCE0Q37460258-76E54D4E-D678-446D-8000-2073027B212DQ37475022-8186C1AA-0AEE-4C52-809B-9B6818FDD028Q37689865-E5756A70-E064-4894-8FBD-0529B8D4CCBCQ37991814-038FB359-DD48-49B0-ACA7-B326BC70972DQ38293081-C0F486CC-91E8-4C46-AE27-CFE6A757C83DQ39011074-4E6FA23F-1214-4EDE-B4C9-B7B89A3197E5Q40336954-F3ADABB9-3276-4DCE-A5F8-CE3EA83997F5Q40340100-F0EE4EB5-DCB5-455B-AD6E-B6F1BA8BB830Q41024589-E88504CC-61E6-4EE8-ACAB-59159FCB6397
P2860
Characterization of serum platelet-activating factor (PAF) acetylhydrolase. Correlation between deficiency of serum PAF acetylhydrolase and respiratory symptoms in asthmatic children
description
1988 nî lūn-bûn
@nan
1988年の論文
@ja
1988年論文
@yue
1988年論文
@zh-hant
1988年論文
@zh-hk
1988年論文
@zh-mo
1988年論文
@zh-tw
1988年论文
@wuu
1988年论文
@zh
1988年论文
@zh-cn
name
Characterization of serum plat ...... symptoms in asthmatic children
@ast
Characterization of serum plat ...... symptoms in asthmatic children
@en
type
label
Characterization of serum plat ...... symptoms in asthmatic children
@ast
Characterization of serum plat ...... symptoms in asthmatic children
@en
prefLabel
Characterization of serum plat ...... symptoms in asthmatic children
@ast
Characterization of serum plat ...... symptoms in asthmatic children
@en
P2093
P2860
P356
P1476
Characterization of serum plat ...... symptoms in asthmatic children
@en
P2093
J Sugatani
M Matsumoto
T Yamanaka
P2860
P304
P356
10.1172/JCI113818
P407
P577
1988-12-01T00:00:00Z